353 related articles for article (PubMed ID: 24028417)
1. Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Atanasković-Marković M; Medjo B; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Nestorović B
Pediatr Allergy Immunol; 2013 Nov; 24(7):645-9. PubMed ID: 24028417
[No Abstract] [Full Text] [Related]
2. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
[No Abstract] [Full Text] [Related]
3. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
[TBL] [Abstract][Full Text] [Related]
4. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Treat J
Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
[No Abstract] [Full Text] [Related]
8. [Severe delayed drug hypersensitivity reactions].
Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
[TBL] [Abstract][Full Text] [Related]
9. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
van der Meer JB
Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
[No Abstract] [Full Text] [Related]
10. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
Sanclemente G; De la Roche CA; Escobar CE; Falabella R
Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
[No Abstract] [Full Text] [Related]
11. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JK; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KM; Wong GA; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
Br J Dermatol; 2016 Jun; 174(6):1194-227. PubMed ID: 27317286
[No Abstract] [Full Text] [Related]
12. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome due to carbamazepine.
Ramadasan P; Chaudhury S; Vaishampayne S; John TR
J Assoc Physicians India; 2000 Jul; 48(7):742-3. PubMed ID: 11273515
[TBL] [Abstract][Full Text] [Related]
14. [Toxic epidermal necrolysis (Lyell syndrome), a lifethreatening emergency of introgenic origin].
Piérard GE; Jennes S; Piérard-Franchimont C
Rev Med Liege; 2016 Oct; 71(10):435-439. PubMed ID: 28383851
[TBL] [Abstract][Full Text] [Related]
15. [Stevens-Johnson syndrome in the literature and authors' own studies].
Chłystowska M; Pietruszka-Chmarra A; Szafrański T; Michalak J
Med Wieku Rozwoj; 2008; 12(3):799-803. PubMed ID: 19305034
[TBL] [Abstract][Full Text] [Related]
16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
17. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
18. Severe adverse cutaneous reactions to drugs.
Roujeau JC; Stern RS
N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310
[No Abstract] [Full Text] [Related]
19. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
